Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Shares Outstanding (Weighted Average): 2012-2025

Historic Shares Outstanding (Weighted Average) for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $78.7 million.

  • Veracyte's Shares Outstanding (Weighted Average) rose 2.42% to $78.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.7 million, marking a year-over-year increase of 2.42%. This contributed to the annual value of $77.5 million for FY2024, which is 6.11% up from last year.
  • Veracyte's Shares Outstanding (Weighted Average) amounted to $78.7 million in Q3 2025, which was up 0.46% from $78.3 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Shares Outstanding (Weighted Average) peaked at $78.7 million during Q3 2025, and registered a low of $67.0 million during Q1 2021.
  • For the 3-year period, Veracyte's Shares Outstanding (Weighted Average) averaged around $75.6 million, with its median value being $76.4 million (2024).
  • Data for Veracyte's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 34.71% (in 2021) over the last 5 years.
  • Veracyte's Shares Outstanding (Weighted Average) (Quarterly) stood at $71.0 million in 2021, then rose by 1.00% to $71.8 million in 2022, then grew by 1.79% to $73.0 million in 2023, then increased by 6.11% to $77.5 million in 2024, then grew by 2.42% to $78.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $78.7 million in Q3 2025, compared to $78.3 million in Q2 2025 and $77.9 million in Q1 2025.